Skip to main content
Premium Trial:

Request an Annual Quote

Bruker Shares Drop 8.1 Percent

Shares of Bruker Biosciences declined 8.1 percent for the week ended Tuesday to lead decliners in the BCW Index. The drop took place mostly on Monday, after the firm announced that it would offer 10.4 million shares of common stock (see Briefs).
 
GE led gainers for the week with a 6.6 percent rise in share price, followed by Thermo Fisher Scientific, which climbed 3.7 percent.
 
Overall, the Index closed up .2 percent. Meanwhile, the Dow Jones Industrial Average gained 1.3 percent for the tracking period, the Nasdaq fell .1 percent, and the Nasdaq Biotech Index dropped 1 percent.

 
BioCommerce Week Index of Diversified
Molecular Biology Tool Companies
Company
Ticker
Current Price
(December 19, 2006)
Last
Price
December 12, 2006)
% change
Agilent A
34.12
33.86
0.8
Applied Biosystems ABI
37.72
37.54
0.5
Beckman BEC
59.91
59.38
0.9
Bio-Rad BIO
81.82
84.01
-2.6
Bruker BRKR
7.33
7.98
-8.1
GE GE
38.01
35.64
6.6
Invitrogen IVGN
56.30
57.67
-2.4
Millipore MIL
68.74
68.79
-0.1
Molecular Devices MDCC
21.87
22.53
-2.9
PerkinElmer PKI
22.21
22.26
-0.2
Qiagen QGEN
15.37
14.98
2.6
Sigma SIAL
78.82
77.83
1.3
Stratagene STGN
7.30
7.52
-2.9
Thermo TMO
46.13
44.50
3.7
Waters WAT
49.73
49.39
0.7
BCW Index Average  
41.69
41.59
0.2
The Scan

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.

Study Tracks Outcomes in Children Born to Zika Virus-Infected Mothers

By following pregnancy outcomes for women with RT-PCR-confirmed Zika virus infections, researchers saw in Lancet Regional Health congenital abnormalities in roughly one-third of live-born children.

Team Presents Benchmark Study of RNA Classification Tools

With more than 135 transcriptomic datasets, researchers tested two dozen coding and non-coding RNA classification tools, establishing a set of potentially misclassified transcripts, as they report in Nucleic Acids Research.

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.